Albemarle Co. (NYSE:ALB - Get Free Report) shares shot up 4.5% on Monday . The stock traded as high as $79.63 and last traded at $78.90. 570,031 shares were traded during trading, a decline of 78% from the average session volume of 2,613,264 shares. The stock had previously closed at $75.51.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on ALB. Piper Sandler reduced their target price on Albemarle from $90.00 to $85.00 and set an "underweight" rating for the company in a research note on Thursday, February 20th. Truist Financial cut their target price on Albemarle from $96.00 to $85.00 and set a "hold" rating on the stock in a research report on Friday, February 14th. Clarkson Capital started coverage on shares of Albemarle in a research note on Tuesday, January 14th. They set a "buy" rating and a $112.00 target price for the company. UBS Group decreased their target price on Albemarle from $99.00 to $86.00 and set a "neutral" rating for the company in a research report on Thursday, February 13th. Finally, Citigroup dropped their price objective on Albemarle from $115.00 to $85.00 and set a "neutral" rating on the stock in a report on Wednesday, February 12th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $107.05.
View Our Latest Analysis on ALB
Albemarle Trading Up 0.4 %
The business's 50-day moving average price is $83.92 and its 200-day moving average price is $91.94. The firm has a market capitalization of $8.92 billion, a PE ratio of -6.77 and a beta of 1.70. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.95 and a quick ratio of 1.19.
Albemarle (NYSE:ALB - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. As a group, analysts expect that Albemarle Co. will post -0.04 earnings per share for the current fiscal year.
Albemarle Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Friday, March 14th will be paid a $0.405 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.62 annualized dividend and a yield of 2.14%. Albemarle's dividend payout ratio is presently -14.46%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Quarry LP grew its stake in Albemarle by 1,400.0% during the third quarter. Quarry LP now owns 270 shares of the specialty chemicals company's stock worth $26,000 after buying an additional 252 shares during the last quarter. Assetmark Inc. raised its position in shares of Albemarle by 340.6% in the 4th quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 235 shares during the period. Trust Co. of Vermont raised its holdings in Albemarle by 606.5% in the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company's stock worth $28,000 after purchasing an additional 279 shares during the period. First Community Trust NA grew its holdings in shares of Albemarle by 55.0% in the 4th quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company's stock valued at $34,000 after buying an additional 142 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in Albemarle during the fourth quarter worth about $34,000. Institutional investors and hedge funds own 92.87% of the company's stock.
Albemarle Company Profile
(
Get Free Report)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.